easymize Competitors

It’s always been about people. We founded BambooHR in 2008 with a mission to set people free to do great work—a mission that continues to guide us today. We empower HR pros, employees, and organizations everywhere to simplify complicated processes and streamline time-consuming tasks, so they can focus on supporting their people, thriving in their roles, and growing their business. Serving more than 34,000 customers and 3 million employees across 190 countries, BambooHR is more than just HR software—it’s a complete HR ecosystem designed to manage, protect, enrich, report on, extend, and benchmark people data in a way that drives business goals and smarter decision making. Our vision is to become the #1 HR platform for small and medium-sized businesses (SMBs) around the world, and we empower organizations at every stage to make the most impact. We are proud to serve clients across all industries ranging from startups to household names such as Bitcoin.com, Quora, Le Creuset, MasterClass, and the New York City Ballet. For Customer Support, please reach out to support@bamboohr.com.

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.21 billion in 2025, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social welfare institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. The basis of CompuGroup Medical's services is its unique customer base, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities, as well as insurance and pharmaceutical companies. CompuGroup Medical has offices in 19 countries and offers its solutions in 60 countries worldwide. More than 8,700 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy. Three aspirations drive Sana as we look to discover treatments for patients with poor outcomes or currently untreatable diseases. The first is the ability to repair and control the genes in any cell in the body. We are advancing novel delivery technologies with the goal of being able to deliver any payload to any cell in a specific, predictable, and repeatable manner, paving the way for next-generation in vivo gene therapy. Next is the ability to differentiate pluripotent stem cells ex vivo into immune-cloaked functional cells with the aspiration of being able to replace any missing or damaged cells in the body. Last is a belief we can enable broader access to our therapies through focusing on scalable manufacturing solutions, the cost of manufacturing, and aligning with key stakeholders. Sana launched in early 2019 and has over 350 employees in Seattle, Cambridge, and South San Francisco. Sana was founded with the long view – bringing together great people and the best technologies to deliver on the challenging promise of using engineered cells to meaningfully change the outcome of many human diseases.